nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—TarBasePathway—ERG—sarcoma	0.209	0.627	CbGpPWpGaD
Indapamide—KCNQ1—TarBasePathway—ERG—sarcoma	0.0631	0.189	CbGpPWpGaD
Indapamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.0169	0.0508	CbGpPWpGaD
Indapamide—KCNE1—mammary gland—sarcoma	0.0165	0.145	CbGeAlD
Indapamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—HBA1—sarcoma	0.0162	0.0487	CbGpPWpGaD
Indapamide—KCNE1—hematopoietic system—sarcoma	0.01	0.0883	CbGeAlD
Indapamide—CA2—periosteum—sarcoma	0.00931	0.082	CbGeAlD
Indapamide—KCNE1—testis—sarcoma	0.00549	0.0484	CbGeAlD
Indapamide—KCNQ1—seminal vesicle—sarcoma	0.00484	0.0427	CbGeAlD
Indapamide—CA5B—mammary gland—sarcoma	0.00483	0.0426	CbGeAlD
Indapamide—CA5A—liver—sarcoma	0.00394	0.0347	CbGeAlD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—sarcoma	0.00378	0.0113	CbGpPWpGaD
Indapamide—KCNQ1—cardiac atrium—sarcoma	0.00349	0.0308	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00323	0.00968	CbGpPWpGaD
Indapamide—CA12—connective tissue—sarcoma	0.00316	0.0279	CbGeAlD
Indapamide—KCNQ1—bone marrow—sarcoma	0.00295	0.026	CbGeAlD
Indapamide—CA5B—hematopoietic system—sarcoma	0.00294	0.026	CbGeAlD
Indapamide—CA9—tendon—sarcoma	0.00294	0.0259	CbGeAlD
Indapamide—KCNQ1—testis—sarcoma	0.00252	0.0222	CbGeAlD
Indapamide—CA9—testis—sarcoma	0.00243	0.0214	CbGeAlD
Indapamide—KCNQ1—liver—sarcoma	0.00238	0.021	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.00228	0.00684	CbGpPWpGaD
Indapamide—CA5B—cardiac atrium—sarcoma	0.00224	0.0197	CbGeAlD
Indapamide—CA4—seminal vesicle—sarcoma	0.00214	0.0188	CbGeAlD
Indapamide—CA5B—tendon—sarcoma	0.00195	0.0172	CbGeAlD
Indapamide—CA2—embryo—sarcoma	0.00189	0.0166	CbGeAlD
Indapamide—KCNQ1—lymph node—sarcoma	0.00183	0.0161	CbGeAlD
Indapamide—CA2—seminal vesicle—sarcoma	0.00177	0.0156	CbGeAlD
Indapamide—CA2—hematopoietic system—sarcoma	0.00169	0.0149	CbGeAlD
Indapamide—CA9—Cellular response to hypoxia—VEGFA—sarcoma	0.00167	0.005	CbGpPWpGaD
Indapamide—CA2—connective tissue—sarcoma	0.00162	0.0143	CbGeAlD
Indapamide—CA5B—testis—sarcoma	0.00161	0.0142	CbGeAlD
Indapamide—CA4—cardiac atrium—sarcoma	0.00154	0.0136	CbGeAlD
Indapamide—CA2—smooth muscle tissue—sarcoma	0.00148	0.0131	CbGeAlD
Indapamide—CA2—skin of body—sarcoma	0.00147	0.0129	CbGeAlD
Indapamide—CA4—tendon—sarcoma	0.00135	0.0119	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00133	0.00399	CbGpPWpGaD
Indapamide—CA4—bone marrow—sarcoma	0.0013	0.0115	CbGeAlD
Indapamide—CA2—cardiac atrium—sarcoma	0.00128	0.0113	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.00122	0.00366	CbGpPWpGaD
Indapamide—CA2—lymphoid tissue—sarcoma	0.00119	0.0105	CbGeAlD
Indapamide—CA5B—lymph node—sarcoma	0.00117	0.0103	CbGeAlD
Indapamide—CA2—tendon—sarcoma	0.00112	0.00983	CbGeAlD
Indapamide—CA4—testis—sarcoma	0.00111	0.00982	CbGeAlD
Indapamide—CYP3A4—hematopoietic system—sarcoma	0.00109	0.00958	CbGeAlD
Indapamide—CA2—bone marrow—sarcoma	0.00108	0.00952	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000956	0.00287	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000949	0.00284	CbGpPWpGaD
Indapamide—CA2—testis—sarcoma	0.000924	0.00814	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000879	0.00263	CbGpPWpGaD
Indapamide—CA2—liver—sarcoma	0.000873	0.0077	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000835	0.0025	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—CREB1—sarcoma	0.000835	0.0025	CbGpPWpGaD
Indapamide—CA4—lymph node—sarcoma	0.000807	0.00712	CbGeAlD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000768	0.0023	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—MDM2—sarcoma	0.000691	0.00207	CbGpPWpGaD
Indapamide—CA2—lymph node—sarcoma	0.000669	0.0059	CbGeAlD
Indapamide—CYP3A4—liver—sarcoma	0.000563	0.00496	CbGeAlD
Indapamide—Body temperature increased—Mitoxantrone—sarcoma	0.000552	0.000998	CcSEcCtD
Indapamide—Abdominal pain—Mitoxantrone—sarcoma	0.000552	0.000998	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000552	0.000998	CcSEcCtD
Indapamide—Bronchitis—Epirubicin—sarcoma	0.000551	0.000996	CcSEcCtD
Indapamide—Diarrhoea—Dactinomycin—sarcoma	0.000549	0.000993	CcSEcCtD
Indapamide—Nasopharyngitis—Doxorubicin—sarcoma	0.000548	0.000991	CcSEcCtD
Indapamide—Hypotension—Etoposide—sarcoma	0.000543	0.000981	CcSEcCtD
Indapamide—Gastritis—Doxorubicin—sarcoma	0.000542	0.000981	CcSEcCtD
Indapamide—Muscular weakness—Doxorubicin—sarcoma	0.00054	0.000977	CcSEcCtD
Indapamide—Dysuria—Epirubicin—sarcoma	0.000535	0.000968	CcSEcCtD
Indapamide—Dizziness—Thiotepa—sarcoma	0.000535	0.000967	CcSEcCtD
Indapamide—Dysphagia—Doxorubicin—sarcoma	0.00053	0.000958	CcSEcCtD
Indapamide—Asthma—Doxorubicin—sarcoma	0.00053	0.000958	CcSEcCtD
Indapamide—Influenza—Doxorubicin—sarcoma	0.00053	0.000958	CcSEcCtD
Indapamide—Pollakiuria—Epirubicin—sarcoma	0.000529	0.000956	CcSEcCtD
Indapamide—Hypersensitivity—Vincristine—sarcoma	0.000528	0.000955	CcSEcCtD
Indapamide—Photosensitivity reaction—Epirubicin—sarcoma	0.000522	0.000945	CcSEcCtD
Indapamide—Paraesthesia—Etoposide—sarcoma	0.000521	0.000943	CcSEcCtD
Indapamide—Pancreatitis—Doxorubicin—sarcoma	0.000519	0.000939	CcSEcCtD
Indapamide—Weight decreased—Epirubicin—sarcoma	0.000518	0.000937	CcSEcCtD
Indapamide—Dyspnoea—Etoposide—sarcoma	0.000518	0.000936	CcSEcCtD
Indapamide—Hyperglycaemia—Epirubicin—sarcoma	0.000516	0.000934	CcSEcCtD
Indapamide—Somnolence—Etoposide—sarcoma	0.000516	0.000934	CcSEcCtD
Indapamide—Angina pectoris—Doxorubicin—sarcoma	0.000516	0.000933	CcSEcCtD
Indapamide—Hypersensitivity—Mitoxantrone—sarcoma	0.000514	0.00093	CcSEcCtD
Indapamide—Asthenia—Vincristine—sarcoma	0.000514	0.00093	CcSEcCtD
Indapamide—Vomiting—Thiotepa—sarcoma	0.000514	0.00093	CcSEcCtD
Indapamide—Pneumonia—Epirubicin—sarcoma	0.000513	0.000928	CcSEcCtD
Indapamide—Drowsiness—Epirubicin—sarcoma	0.00051	0.000923	CcSEcCtD
Indapamide—Vomiting—Dactinomycin—sarcoma	0.00051	0.000923	CcSEcCtD
Indapamide—Rash—Thiotepa—sarcoma	0.00051	0.000922	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—sarcoma	0.000509	0.000921	CcSEcCtD
Indapamide—Dermatitis—Thiotepa—sarcoma	0.000509	0.000921	CcSEcCtD
Indapamide—Headache—Thiotepa—sarcoma	0.000506	0.000916	CcSEcCtD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000506	0.00152	CbGpPWpGaD
Indapamide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000506	0.000915	CcSEcCtD
Indapamide—Rash—Dactinomycin—sarcoma	0.000506	0.000915	CcSEcCtD
Indapamide—Decreased appetite—Etoposide—sarcoma	0.000505	0.000913	CcSEcCtD
Indapamide—Renal failure—Epirubicin—sarcoma	0.000502	0.000907	CcSEcCtD
Indapamide—Gastrointestinal disorder—Etoposide—sarcoma	0.000501	0.000907	CcSEcCtD
Indapamide—Asthenia—Mitoxantrone—sarcoma	0.000501	0.000906	CcSEcCtD
Indapamide—Fatigue—Etoposide—sarcoma	0.000501	0.000905	CcSEcCtD
Indapamide—Stomatitis—Epirubicin—sarcoma	0.000498	0.0009	CcSEcCtD
Indapamide—Jaundice—Epirubicin—sarcoma	0.000498	0.0009	CcSEcCtD
Indapamide—Pain—Etoposide—sarcoma	0.000497	0.000898	CcSEcCtD
Indapamide—Constipation—Etoposide—sarcoma	0.000497	0.000898	CcSEcCtD
Indapamide—Conjunctivitis—Epirubicin—sarcoma	0.000496	0.000897	CcSEcCtD
Indapamide—Urinary tract infection—Epirubicin—sarcoma	0.000496	0.000897	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—sarcoma	0.000495	0.000896	CcSEcCtD
Indapamide—Diarrhoea—Vincristine—sarcoma	0.00049	0.000887	CcSEcCtD
Indapamide—Sweating—Epirubicin—sarcoma	0.000489	0.000885	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—sarcoma	0.000489	0.000885	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—sarcoma	0.000483	0.000874	CcSEcCtD
Indapamide—Hepatobiliary disease—Epirubicin—sarcoma	0.000483	0.000873	CcSEcCtD
Indapamide—Nausea—Thiotepa—sarcoma	0.00048	0.000868	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—sarcoma	0.000479	0.000867	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—sarcoma	0.000479	0.000866	CcSEcCtD
Indapamide—Feeling abnormal—Etoposide—sarcoma	0.000479	0.000865	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—sarcoma	0.000478	0.000864	CcSEcCtD
Indapamide—Diarrhoea—Mitoxantrone—sarcoma	0.000478	0.000864	CcSEcCtD
Indapamide—Nausea—Dactinomycin—sarcoma	0.000477	0.000862	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—sarcoma	0.000476	0.000861	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—sarcoma	0.000475	0.000859	CcSEcCtD
Indapamide—Gastrointestinal pain—Etoposide—sarcoma	0.000475	0.000859	CcSEcCtD
Indapamide—Dizziness—Vincristine—sarcoma	0.000474	0.000857	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—sarcoma	0.000472	0.000854	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000468	0.000847	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—sarcoma	0.000464	0.00084	CcSEcCtD
Indapamide—Urticaria—Etoposide—sarcoma	0.000461	0.000834	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—sarcoma	0.00046	0.000833	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—sarcoma	0.00046	0.000833	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—sarcoma	0.000459	0.000831	CcSEcCtD
Indapamide—Body temperature increased—Etoposide—sarcoma	0.000459	0.00083	CcSEcCtD
Indapamide—Abdominal pain—Etoposide—sarcoma	0.000459	0.00083	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—sarcoma	0.000459	0.00083	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—sarcoma	0.000459	0.00083	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—sarcoma	0.000458	0.000829	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—sarcoma	0.000456	0.000824	CcSEcCtD
Indapamide—Vomiting—Vincristine—sarcoma	0.000456	0.000824	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—sarcoma	0.000455	0.000822	CcSEcCtD
Indapamide—Sweating—Doxorubicin—sarcoma	0.000453	0.000819	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—sarcoma	0.000452	0.000818	CcSEcCtD
Indapamide—Rash—Vincristine—sarcoma	0.000452	0.000817	CcSEcCtD
Indapamide—Dermatitis—Vincristine—sarcoma	0.000452	0.000817	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—sarcoma	0.000451	0.000816	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—sarcoma	0.000449	0.000812	CcSEcCtD
Indapamide—Headache—Vincristine—sarcoma	0.000449	0.000812	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000447	0.000808	CcSEcCtD
Indapamide—Vomiting—Mitoxantrone—sarcoma	0.000444	0.000803	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—sarcoma	0.000443	0.000801	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—sarcoma	0.000442	0.000799	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—sarcoma	0.000441	0.000797	CcSEcCtD
Indapamide—Rash—Mitoxantrone—sarcoma	0.00044	0.000796	CcSEcCtD
Indapamide—Dermatitis—Mitoxantrone—sarcoma	0.00044	0.000795	CcSEcCtD
Indapamide—Headache—Mitoxantrone—sarcoma	0.000437	0.000791	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—sarcoma	0.000433	0.000783	CcSEcCtD
Indapamide—Hypersensitivity—Etoposide—sarcoma	0.000428	0.000774	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—sarcoma	0.000427	0.000773	CcSEcCtD
Indapamide—Nausea—Vincristine—sarcoma	0.000426	0.00077	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—sarcoma	0.000425	0.000769	CcSEcCtD
Indapamide—Flushing—Epirubicin—sarcoma	0.000425	0.000769	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—sarcoma	0.000425	0.000769	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—sarcoma	0.000424	0.000767	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—sarcoma	0.000422	0.000763	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—sarcoma	0.000421	0.000761	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—sarcoma	0.000419	0.000757	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—sarcoma	0.000418	0.000755	CcSEcCtD
Indapamide—Asthenia—Etoposide—sarcoma	0.000417	0.000754	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—sarcoma	0.000416	0.000752	CcSEcCtD
Indapamide—Nausea—Mitoxantrone—sarcoma	0.000415	0.00075	CcSEcCtD
Indapamide—Pruritus—Etoposide—sarcoma	0.000411	0.000743	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—sarcoma	0.000409	0.00074	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—sarcoma	0.000409	0.000739	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—sarcoma	0.000401	0.000725	CcSEcCtD
Indapamide—CA5A—Metabolism—ENO2—sarcoma	0.000399	0.0012	CbGpPWpGaD
Indapamide—Erythema—Epirubicin—sarcoma	0.000399	0.000721	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—sarcoma	0.000399	0.000721	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—sarcoma	0.000397	0.000719	CcSEcCtD
Indapamide—CA5A—Metabolism—HBA1—sarcoma	0.000397	0.00119	CbGpPWpGaD
Indapamide—Tinnitus—Doxorubicin—sarcoma	0.000395	0.000715	CcSEcCtD
Indapamide—Flushing—Doxorubicin—sarcoma	0.000393	0.000712	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—sarcoma	0.000393	0.000712	CcSEcCtD
Indapamide—Flatulence—Epirubicin—sarcoma	0.000393	0.000711	CcSEcCtD
Indapamide—Tension—Epirubicin—sarcoma	0.000391	0.000708	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—sarcoma	0.000391	0.000706	CcSEcCtD
Indapamide—Nervousness—Epirubicin—sarcoma	0.000387	0.000701	CcSEcCtD
Indapamide—Back pain—Epirubicin—sarcoma	0.000386	0.000698	CcSEcCtD
Indapamide—Dizziness—Etoposide—sarcoma	0.000384	0.000694	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—sarcoma	0.000383	0.000694	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—HRAS—sarcoma	0.000379	0.00114	CbGpPWpGaD
Indapamide—Arrhythmia—Doxorubicin—sarcoma	0.000379	0.000685	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—sarcoma	0.000376	0.00068	CcSEcCtD
Indapamide—CA5B—Metabolism—ENO2—sarcoma	0.000373	0.00112	CbGpPWpGaD
Indapamide—CA7—Metabolism—ENO2—sarcoma	0.000373	0.00112	CbGpPWpGaD
Indapamide—CA7—Metabolism—HBA1—sarcoma	0.00037	0.00111	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HBA1—sarcoma	0.00037	0.00111	CbGpPWpGaD
Indapamide—Ill-defined disorder—Epirubicin—sarcoma	0.00037	0.000669	CcSEcCtD
Indapamide—Vomiting—Etoposide—sarcoma	0.000369	0.000668	CcSEcCtD
Indapamide—Erythema—Doxorubicin—sarcoma	0.000369	0.000667	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—sarcoma	0.000369	0.000667	CcSEcCtD
Indapamide—Anaemia—Epirubicin—sarcoma	0.000369	0.000667	CcSEcCtD
Indapamide—Agitation—Epirubicin—sarcoma	0.000367	0.000663	CcSEcCtD
Indapamide—Rash—Etoposide—sarcoma	0.000366	0.000662	CcSEcCtD
Indapamide—Dermatitis—Etoposide—sarcoma	0.000366	0.000662	CcSEcCtD
Indapamide—Headache—Etoposide—sarcoma	0.000364	0.000658	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—sarcoma	0.000364	0.000658	CcSEcCtD
Indapamide—Tension—Doxorubicin—sarcoma	0.000362	0.000655	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—sarcoma	0.000361	0.000654	CcSEcCtD
Indapamide—Malaise—Epirubicin—sarcoma	0.00036	0.00065	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—sarcoma	0.000358	0.000648	CcSEcCtD
Indapamide—Vertigo—Epirubicin—sarcoma	0.000358	0.000648	CcSEcCtD
Indapamide—Syncope—Epirubicin—sarcoma	0.000358	0.000647	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—sarcoma	0.000357	0.000646	CcSEcCtD
Indapamide—Back pain—Doxorubicin—sarcoma	0.000357	0.000646	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—sarcoma	0.000355	0.000642	CcSEcCtD
Indapamide—Palpitations—Epirubicin—sarcoma	0.000352	0.000637	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—sarcoma	0.000351	0.000634	CcSEcCtD
Indapamide—Cough—Epirubicin—sarcoma	0.000348	0.000629	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—sarcoma	0.000348	0.000629	CcSEcCtD
Indapamide—CA12—Metabolism—ENO2—sarcoma	0.000345	0.00103	CbGpPWpGaD
Indapamide—Nausea—Etoposide—sarcoma	0.000345	0.000624	CcSEcCtD
Indapamide—CA12—Metabolism—HBA1—sarcoma	0.000343	0.00103	CbGpPWpGaD
Indapamide—Ill-defined disorder—Doxorubicin—sarcoma	0.000342	0.000619	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—sarcoma	0.000341	0.000617	CcSEcCtD
Indapamide—Chest pain—Epirubicin—sarcoma	0.00034	0.000614	CcSEcCtD
Indapamide—Myalgia—Epirubicin—sarcoma	0.00034	0.000614	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—sarcoma	0.00034	0.000614	CcSEcCtD
Indapamide—Agitation—Doxorubicin—sarcoma	0.000339	0.000613	CcSEcCtD
Indapamide—CA5A—Metabolism—PLCG1—sarcoma	0.000339	0.00102	CbGpPWpGaD
Indapamide—Anxiety—Epirubicin—sarcoma	0.000338	0.000612	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000337	0.00061	CcSEcCtD
Indapamide—Discomfort—Epirubicin—sarcoma	0.000335	0.000607	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—MDM2—sarcoma	0.000334	0.001	CbGpPWpGaD
Indapamide—Malaise—Doxorubicin—sarcoma	0.000333	0.000602	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—sarcoma	0.000332	0.000601	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—sarcoma	0.000332	0.0006	CcSEcCtD
Indapamide—Syncope—Doxorubicin—sarcoma	0.000331	0.000599	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—sarcoma	0.00033	0.000597	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—sarcoma	0.000326	0.00059	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—sarcoma	0.000326	0.000589	CcSEcCtD
Indapamide—Oedema—Epirubicin—sarcoma	0.000326	0.000589	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—sarcoma	0.000324	0.000587	CcSEcCtD
Indapamide—Infection—Epirubicin—sarcoma	0.000323	0.000585	CcSEcCtD
Indapamide—Cough—Doxorubicin—sarcoma	0.000322	0.000582	CcSEcCtD
Indapamide—Shock—Epirubicin—sarcoma	0.00032	0.000579	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—sarcoma	0.000319	0.000577	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—sarcoma	0.000319	0.000576	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—sarcoma	0.000318	0.000575	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—sarcoma	0.000316	0.000572	CcSEcCtD
Indapamide—CA7—Metabolism—PLCG1—sarcoma	0.000316	0.000948	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PLCG1—sarcoma	0.000316	0.000948	CbGpPWpGaD
Indapamide—Hyperhidrosis—Epirubicin—sarcoma	0.000315	0.000569	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—sarcoma	0.000314	0.000568	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—sarcoma	0.000314	0.000568	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—sarcoma	0.000314	0.000568	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—sarcoma	0.000313	0.000566	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000312	0.000564	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—sarcoma	0.00031	0.000561	CcSEcCtD
Indapamide—Anorexia—Epirubicin—sarcoma	0.00031	0.000561	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—sarcoma	0.000307	0.000556	CcSEcCtD
Indapamide—Hypotension—Epirubicin—sarcoma	0.000304	0.00055	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—sarcoma	0.000301	0.000545	CcSEcCtD
Indapamide—Oedema—Doxorubicin—sarcoma	0.000301	0.000545	CcSEcCtD
Indapamide—Infection—Doxorubicin—sarcoma	0.000299	0.000541	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000297	0.000536	CcSEcCtD
Indapamide—Shock—Doxorubicin—sarcoma	0.000296	0.000536	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—sarcoma	0.000295	0.000534	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000295	0.000533	CcSEcCtD
Indapamide—Insomnia—Epirubicin—sarcoma	0.000294	0.000532	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—sarcoma	0.000294	0.000532	CcSEcCtD
Indapamide—CA12—Metabolism—PLCG1—sarcoma	0.000293	0.000878	CbGpPWpGaD
Indapamide—Skin disorder—Doxorubicin—sarcoma	0.000293	0.000529	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—sarcoma	0.000292	0.000529	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—sarcoma	0.000291	0.000527	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—sarcoma	0.00029	0.000525	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—JUN—sarcoma	0.00029	0.000869	CbGpPWpGaD
Indapamide—Somnolence—Epirubicin—sarcoma	0.000289	0.000523	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—sarcoma	0.000287	0.000519	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—sarcoma	0.000287	0.000518	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—sarcoma	0.000283	0.000512	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—sarcoma	0.000281	0.000509	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000281	0.000508	CcSEcCtD
Indapamide—Fatigue—Epirubicin—sarcoma	0.000281	0.000508	CcSEcCtD
Indapamide—Pain—Epirubicin—sarcoma	0.000278	0.000503	CcSEcCtD
Indapamide—Constipation—Epirubicin—sarcoma	0.000278	0.000503	CcSEcCtD
Indapamide—CA4—Metabolism—ENO2—sarcoma	0.000275	0.000825	CbGpPWpGaD
Indapamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000274	0.000496	CcSEcCtD
Indapamide—CA4—Metabolism—HBA1—sarcoma	0.000274	0.00082	CbGpPWpGaD
Indapamide—Insomnia—Doxorubicin—sarcoma	0.000272	0.000493	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—sarcoma	0.00027	0.000489	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—sarcoma	0.000269	0.000486	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—sarcoma	0.000268	0.000485	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—sarcoma	0.000268	0.000484	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000266	0.000481	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—sarcoma	0.000265	0.000479	CcSEcCtD
Indapamide—CA2—Metabolism—ENO2—sarcoma	0.000264	0.000791	CbGpPWpGaD
Indapamide—CA2—Metabolism—HBA1—sarcoma	0.000262	0.000786	CbGpPWpGaD
Indapamide—Decreased appetite—Doxorubicin—sarcoma	0.000262	0.000474	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00026	0.00047	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—sarcoma	0.00026	0.00047	CcSEcCtD
Indapamide—Urticaria—Epirubicin—sarcoma	0.000259	0.000468	CcSEcCtD
Indapamide—Pain—Doxorubicin—sarcoma	0.000258	0.000466	CcSEcCtD
Indapamide—Constipation—Doxorubicin—sarcoma	0.000258	0.000466	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—sarcoma	0.000257	0.000465	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—sarcoma	0.000257	0.000465	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—VEGFA—sarcoma	0.000253	0.000759	CbGpPWpGaD
Indapamide—Feeling abnormal—Doxorubicin—sarcoma	0.000248	0.000449	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000246	0.000445	CcSEcCtD
Indapamide—Hypersensitivity—Epirubicin—sarcoma	0.00024	0.000434	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—sarcoma	0.000239	0.000433	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—sarcoma	0.000238	0.000431	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—sarcoma	0.000238	0.000431	CcSEcCtD
Indapamide—Asthenia—Epirubicin—sarcoma	0.000234	0.000422	CcSEcCtD
Indapamide—CA4—Metabolism—PLCG1—sarcoma	0.000234	0.0007	CbGpPWpGaD
Indapamide—Pruritus—Epirubicin—sarcoma	0.00023	0.000417	CcSEcCtD
Indapamide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000227	0.000681	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLCG1—sarcoma	0.000224	0.000671	CbGpPWpGaD
Indapamide—Diarrhoea—Epirubicin—sarcoma	0.000223	0.000403	CcSEcCtD
Indapamide—CA9—Metabolism—ENO2—sarcoma	0.000222	0.000667	CbGpPWpGaD
Indapamide—Hypersensitivity—Doxorubicin—sarcoma	0.000222	0.000401	CcSEcCtD
Indapamide—CA9—Metabolism—HBA1—sarcoma	0.000221	0.000663	CbGpPWpGaD
Indapamide—Asthenia—Doxorubicin—sarcoma	0.000216	0.000391	CcSEcCtD
Indapamide—Dizziness—Epirubicin—sarcoma	0.000215	0.000389	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—sarcoma	0.000213	0.000385	CcSEcCtD
Indapamide—Vomiting—Epirubicin—sarcoma	0.000207	0.000374	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—sarcoma	0.000206	0.000373	CcSEcCtD
Indapamide—Rash—Epirubicin—sarcoma	0.000205	0.000371	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—sarcoma	0.000205	0.000371	CcSEcCtD
Indapamide—Headache—Epirubicin—sarcoma	0.000204	0.000369	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—sarcoma	0.000199	0.00036	CcSEcCtD
Indapamide—Nausea—Epirubicin—sarcoma	0.000193	0.00035	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—sarcoma	0.000192	0.000346	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—TP53—sarcoma	0.000191	0.000574	CbGpPWpGaD
Indapamide—Rash—Doxorubicin—sarcoma	0.00019	0.000343	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—sarcoma	0.00019	0.000343	CcSEcCtD
Indapamide—CA9—Metabolism—PLCG1—sarcoma	0.000189	0.000566	CbGpPWpGaD
Indapamide—Headache—Doxorubicin—sarcoma	0.000189	0.000341	CcSEcCtD
Indapamide—Nausea—Doxorubicin—sarcoma	0.000179	0.000324	CcSEcCtD
Indapamide—CYP3A4—Metabolism—ENO2—sarcoma	3.74e-05	0.000112	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HBA1—sarcoma	3.72e-05	0.000112	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLCG1—sarcoma	3.18e-05	9.52e-05	CbGpPWpGaD
